Merck & Co., Inc.MRK

Where MRK's Net Debt / EBITDA sits inside its own 10-year distribution, with the yearly high, low and average.

$150.33-2.01 (-1.32%)Previous close
NYSEHealthcare

MRK Net Debt / EBITDA: current value, 10-year range and year-by-year history

Net Debt / EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
MRK Net Debt / EBITDA historyMRK Net Debt / EBITDA from Sep 2023 to Jun 2026: low 0.84, high 4.26, latest 3.4.0.571.562.553.544.53Sep 23Mar 24Sep 24Jun 25Dec 25Jun 26med 1.28

MRK Net Debt / EBITDA by year

Yearly range of MRK’s net debt / ebitda from 2016 to 2026. Over the full period it ranged from 0.8 to 4.3, averaging 1.6.

MRK Net Debt / EBITDA — yearly low, average, high and year-end values
YearLowAverageHighYear-end
20262.32.93.43.4
20250.81.11.31.3
20241.01.73.21.0
20231.12.64.34.3
20220.91.01.20.9
20211.41.72.21.5
20201.21.52.22.2
20191.11.21.31.1
20181.21.41.71.2
20171.51.72.21.5
20161.31.51.71.7

Get notified when MRK Net Debt / EBITDA crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How many years of operating earnings it would take to pay off the company's net debt. The most common leverage ratio — higher means more financial risk and less flexibility.

Formula(Total Debt − Cash) / EBITDA
Full guide
How to read this chart

Watch the trend more than the level. Declining ratio = deleveraging, growing financial flexibility. Rising ratio = increasing leverage, which constrains dividends, buybacks, and future investment.

Key caveats
  • Sector context is essential: 3× is aggressive for a consumer brand but normal for a regulated utility. Always compare to sector peers.
  • Large acquisitions spike the ratio temporarily — check whether the integration plan credibly drives paydown.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.